Back to LXRX
D. E. Shaw & Co., Inc. LXRX Position History
Lexicon Pharmaceuticals, Inc.
Quarters held
9
Latest value
$53K
Q2 2026
Peak value
$4.8M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $4.4M |
| Q2 2022 | $1.6M |
| Q3 2022 | $4.8M |
| Q3 2022 | $2.5M |
| Q4 2022 | $2.1M |
| Q4 2022 | $3.8M |
| Q4 2023 | $550K |
| Q2 2025 | $22K |
| Q2 2026 | $53K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $53K | 22.2K | — | — |
| Q2 2025 | $22K | 23.7K | — | — |
| Q4 2023 | $550K | 359.2K | — | — |
| Q4 2022 | $3.8M | 1.98M | — | — |
| Q4 2022 | $2.1M | 1.10M | — | — |
| Q3 2022 | $2.5M | 1.03M | — | — |
| Q3 2022 | $4.8M | 2.01M | — | — |
| Q2 2022 | $1.6M | 848.0K | — | — |
| Q2 2022 | $4.4M | 2.38M | — | — |